B38.1

Clinical Causes: Inhalation of airborne spores of the Coccidioides fungi, typically in endemic areas Prolonged exposure to dusty environments or activities that disturb contaminated soil Occupational exposure such as construction, farming, or archaeology in endemic regions Weak immune system or existing lung conditions increasing susceptibility

Key Symptoms: Persistent cough often producing sputum or blood Chest pain or discomfort Shortness of breath, especially with exertion Fatigue and malaise Fever, which may be low-grade or absent in some cases Night sweats Weight loss and loss of appetite Possible formation of lung nodules or cavities visible on imaging

Diagnosis Path: Diagnosis of chronic pulmonary coccidioidomycosis involves a combination of clinical assessment and laboratory testing. Healthcare providers typically use the following methods: - Chest X-rays or CT scans to identify lung abnormalities such as nodules, cavities, or areas of consolidation. - Serologic tests detecting antibodies against Coccidioides, including enzyme immunoassays or immunodiffusion. - Microbiological cultures from sputum samples or lung tissue to identify the fungus. - Histopathological examination when tissue biopsy is performed. Due to the overlap of symptoms with other respiratory conditions, accurate diagnosis often requires a comprehensive assessment by specialists familiar with fungal infections.

Treatment Protocols: Managing chronic pulmonary coccidioidomycosis typically involves antifungal medication, with the choice and duration tailored to the severity of the disease. Common treatment options include: - Azole antifungals such as fluconazole or itraconazole, often prescribed for several months to years depending on response. - Amphotericin B in severe or resistant cases, administered intravenously. - Monitoring for side effects of long-term antifungal therapy. - Symptomatic management for cough or chest discomfort. - Regular follow-up imaging and laboratory tests to assess treatment effectiveness and disease progression. In some cases, surgical intervention may be necessary to remove damaged lung tissue or cavities, especially when complications like recurrent infections or substantial lung destruction occur. Importantly, ongoing care and monitoring are crucial for managing this persistent fungal infection.